Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds

NCT01434914 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped early termination due to poor recruitment

Conditions

Ulcus Cruris

Interventions

DRUG: octenisept®
DRUG: Placebo

Sponsor

Schülke & Mayr GmbH